ARCHIVES

Dasatinib, Nilotinib Show Strong Early Results As Frontline Therapy For CML

This article is from The Cancer Letter archive.

Vol. 30 No. 12 | December 28, 2007

Download PDF Visit The Full Archive

Related Articles

U of Pittsburgh Wins NCI Grant To Include End-of-Life Issues In Med. School Curriculum.

July 6, 2001

In Brief: Friends of Cancer Research Honor Specter; Dole Tapes Announcement For CaP CURE

January 24, 1997

Loss Of Core Grants Imperials Status Of Three Comprehensive Cancer Centers

July 14, 1989

Duke Officials Decline To Provide Details Of Probe

July 23, 2010

NCI To File Record No. Of INDS In ’92, Expand Phase 1 Trials

March 6, 1992

Adcetris Granted Approval For Hodgkin’s Lymphoma and ALCL

September 30, 2011